Gregory J. Cost
Gregory J. Cost
Casebia Therapeutics
Dirección de correo verificada de casebia.com
TítuloCitado porAño
Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR‐mediated gene disruption and other applications
CB Brachmann, A Davies, GJ Cost, E Caputo, J Li, P Hieter, JD Boeke
Yeast 14 (2), 115-132, 1998
29171998
A TALE nuclease architecture for efficient genome editing
JC Miller, S Tan, G Qiao, KA Barlow, J Wang, DF Xia, X Meng, ...
Nature biotechnology 29 (2), 143, 2011
19912011
Genetic engineering of human ES and iPS cells using TALE nucleases
D Hockemeyer, H Wang, S Kiani, CS Lai, Q Gao, JP Cassady, GJ Cost, ...
Nature biotechnology 29 (8), 731, 0
1193
Knockout rats via embryo microinjection of zinc-finger nucleases
AM Geurts, GJ Cost, Y Freyvert, B Zeitler, JC Miller, VM Choi, SS Jenkins, ...
Science 325 (5939), 433, 2009
9972009
Knockout rats generated by embryo microinjection of TALENs
L Tesson, C Usal, S Ménoret, E Leung, BJ Niles, S Remy, Y Santiago, ...
Nature biotechnology 29 (8), 695, 2011
6612011
Human l1 retrotransposition is associated with genetic instability in vivo
DE Symer, C Connelly, ST Szak, EM Caputo, GJ Cost, G Parmigiani, ...
Cell 110 (3), 327-338, 2002
4122002
Human L1 element target‐primed reverse transcription in vitro
GJ Cost, Q Feng, A Jacquier, JD Boeke
The EMBO journal 21 (21), 5899-5910, 2002
3942002
Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases
J Hauschild, B Petersen, Y Santiago, AL Queisser, JW Carnwath, ...
Proceedings of the National Academy of Sciences 108 (29), 12013-12017, 2011
3552011
Translating dosage compensation to trisomy 21
J Jiang, Y Jing, GJ Cost, JC Chiang, HJ Kolpa, AM Cotton, DM Carone, ...
Nature 500 (7462), 296, 2013
2532013
Targeting of human retrotransposon integration is directed by the specificity of the L1 endonuclease for regions of unusual DNA structure
GJ Cost, JD Boeke
Biochemistry 37 (51), 18081-18093, 1998
2341998
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
MD Hoban, GJ Cost, MC Mendel, Z Romero, ML Kaufman, AV Joglekar, ...
Blood 125 (17), 2597-2604, 2015
2252015
Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology
SJ Orlando, Y Santiago, RC DeKelver, Y Freyvert, EA Boydston, ...
Nucleic acids research 38 (15), e152-e152, 2010
1922010
Sequence-directed DNA translocation by purified FtsK
PJ Pease, O Levy, GJ Cost, J Gore, JL Ptacin, D Sherratt, C Bustamante, ...
Science 307 (5709), 586-590, 2005
1922005
In vivo cleavage of transgene donors promotes nuclease‐mediated targeted integration
S Cristea, Y Freyvert, Y Santiago, MC Holmes, FD Urnov, PD Gregory, ...
Biotechnology and bioengineering 110 (3), 871-880, 2013
1482013
Highly efficient deletion of FUT8 in CHO cell lines using zinc‐finger nucleases yields cells that produce completely nonfucosylated antibodies
L Malphettes, Y Freyvert, J Chang, PQ Liu, E Chan, JC Miller, Z Zhou, ...
Biotechnology and bioengineering 106 (5), 774-783, 2010
1372010
BAK and BAX deletion using zinc‐finger nucleases yields apoptosis‐resistant CHO cells
GJ Cost, Y Freyvert, A Vafiadis, Y Santiago, JC Miller, E Rebar, ...
Biotechnology and bioengineering 105 (2), 330-340, 2010
1362010
Generation of gene-specific mutated rats using zinc-finger nucleases
AM Geurts, GJ Cost, S Rémy, X Cui, L Tesson, C Usal, S Ménoret, ...
Rat Genomics, 211-225, 2010
1242010
Generation of a triple‐gene knockout mammalian cell line using engineered zinc‐finger nucleases
PQ Liu, EM Chan, GJ Cost, L Zhang, J Wang, JC Miller, DY Guschin, ...
Biotechnology and bioengineering 106 (1), 97-105, 2010
1202010
Designer deletion strains derived from Saccharomyces cerevisiae S288C: A useful set of strains and plasmids for PCR‐mediated gene disruption and other …
C Baker Brachmann, A Davies, GJ Cost, E Caputo, J Li, P Hieter, ...
Yeast 14 (2), 115-132, 1998
1091998
Engineered cleavage half-domains
JC Miller
US Patent 8,034,598, 2011
952011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20